Advanced search
Publication Cover
Substance Abuse Volume 40, 2019 - Issue 3: Special Section on Substance Use Disorder Quality Metrics
Journal homepage
1,757
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems

Amy M. LoreeCenter for Health Policy and Health Services Research, Henry Ford Health System, Detroit, Michigan, USA; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-1634-7343View further author information
, PhDORCID Icon,
Hsueh-Han YehCenter for Health Policy and Health Services Research, Henry Ford Health System, Detroit, Michigan, USA; View further author information
, PhD,
Derek D. SatreDivision of Research, Kaiser Permanente Northern California, Oakland, Colorado, USA; ;Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco, Colorado, USA; View further author information
, PhD,
Andrea H. Kline-SimonDivision of Research, Kaiser Permanente Northern California, Oakland, Colorado, USA; View further author information
, MS,
Bobbi Jo H. YarboroughCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA; View further author information
, PsyD,
Irina V. HallerEssentia Institute of Rural Health, Essentia Health, Duluth, Minnesota, USA; View further author information
, PhD, MS,
Cynthia I. CampbellDivision of Research, Kaiser Permanente Northern California, Oakland, Colorado, USA; View further author information
, PhD, MPH,
Gwen T. LaphamHealth Research Institute, Kaiser Permanente Washington, Seattle, Washington, USA; ;Department of Health Services, University of Washington School of Public Health, Seattle, Washington, USA; View further author information
, PhD, MPH, MSW,
Rulin C. HechterDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA; View further author information
, MD, PhD,
Ingrid A. BinswangerInstitute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA; ;Colorado Permanente Medical Group, Aurora, Colorado, USA; ;Division of General Internal Medicine, University of Colorado School of Medicine, Aurora, Colorado, USAView further author information
, MD, MPH, MS,
Constance WeisnerDivision of Research, Kaiser Permanente Northern California, Oakland, Colorado, USA; ;Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco, Colorado, USA; View further author information
, DrPH, MSW &
Brian K. AhmedaniCenter for Health Policy and Health Services Research, Henry Ford Health System, Detroit, Michigan, USA; View further author information
, PhD, LMSW show all
Pages 311-317 | Published online: 25 Jan 2019

References

  • Center for Behavioral Health Statistics and Quality. 2015 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2016.
  • Wu LT, Ringwalt CL, Williams CE. Use of substance abuse treatment services by persons with mental health and substance use problems. PS. 2003;54:363–369.
  • Edlund MJ, Booth BM, Han X. Who seeks care where? Utilization of mental health and substance use disorder treatment in two national samples of individuals with alcohol use disorders. J Stud Alcohol Drugs. 2012;73:635–646.
  • Harris KM, Edlund MJ. Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatr Serv. 2005;56:954–959.
  • McCabe SE, West BT. The 3-Year course of multiple substance use disorders in the United States: A national longitudinal study. J Clin Psychiatry. 2017;78:e537–e544.
  • Garnick DW, Horgan CM, Chalk M. Performance measures for alcohol and other drug services. Alcohol Res Health. 2006;29:19–26.
  • National Committee for Quality Assurance. HEDIS 2013 Volume 2: Technical Specifications. Washington, DC: National Committee for Quality Assurance; 2013.
  • Watkins KE, Paddock SM, Hudson TJ, et al. Association between quality measures and mortality in individuals with co-occurring mental health and substance use disorders. J Subst Abuse Treat. 2016;69:1–8.
  • Choi S, Adams SM, Morse SA, MacMaster S. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders. Subst. Use Misuse. 2015;50:653–663.
  • Brown CH, Bennett ME, Li L, Bellack AS. Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders. Addict Behav. 2011;36:439–447.
  • Greenfield SF, Brooks AJ, Gordon SM, et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86:1–21.
  • Weisner C, Mertens J, Tam T, Moore C. Factors affecting the initiation of substance abuse treatment in managed care. Addiction. 2001;96:705–716.
  • Mertens JR, Weisner CM. Predictors of substance abuse treatment retention among women and men in an HMO. Alcohol Clin Exp Res. 2000;24:1525–1533.
  • Satre DD, Knight BG, Dickson-Fuhrmann E, Jarvik LF. Substance abuse treatment initiation among older adults in the GET SMART program: effects of depression and cognitive status. Aging Ment Health. 2004;8:346–354.
  • Stinson FS, Grant BF, Dawson DA, et al. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2005;80:105–116.
  • McCabe SE, West BT, Jutkiewicz EM, Boyd CJ. Multiple DSM-5 substance use disorders: A national study of US adults. Hum Psychopharmacol 2017;32:e2625.
  • Weisner C, Campbell CI, Altschuler A, et al. Factors Associated with Healthcare Effectiveness Data and Information Set (HEDIS) Alcohol and Other Drug (AOD) Measure Performance in 2014-2015. Subst Abus In press.
  • National Committee for Quality Assurance. Summary table of measures, product lines and change. HEDIS. 2015;2:8. Available at: http://www.ncqa.org/Portals/0/HEDISQM/Hedis2015/List_of_HEDIS_2015_Measures.pdf.
  • Satre DD, Leibowitz AS, Mertens JR, Weisner C. Advising depression patients to reduce alcohol and drug use: factors associated with provider intervention in outpatient psychiatry. Am J Addict. 2014;23:570–575.
  • Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3:A42.
  • Satre DD, Leibowitz A, Sterling SA, et al. A randomized clinical trial of Motivational Interviewing to reduce alcohol and drug use among patients with depression. J Consult Clin Psychol. 2016;84:571–579.
  • Sterling S, Kline-Simon AH, Jones A, et al. Specialty addiction and psychiatry treatment initiation and engagement: results from an SBIRT randomized trial in pediatrics. J Subst Abuse Treat. 2017;82:48–54.
  • Yarborough BJH, Chi FW, Green CA, et al. Patient and system characteristics associated with performance on the HEDIS measures of alcohol and other drug treatment initiation and engagement. J Addict Med 2018;12:278-286.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.